Over the past 40 years, Reed Smith has built a reputation for successfully representing global life science and health care companies in complex corporate and regulatory matters, key transactions, and high-profile, “bet the company” litigation. Few, if any, firms can match Reed Smith’s dedication to this sector. To formalize Reed Smith’s interdisciplinary approach, the firm’s Life Sciences Health Industry (LSHI) Group comprises nearly 200 professionals across numerous practice areas who are dedicated to our clients who help save patients’ lives and preserve their health, whether through biotechnology, pharmaceuticals, medical devices, life sciences or delivering health care.
Dedicated to addressing and solving the problems of businesses operating in these sectors, the LSHI Group aims to harmonize the client experience by bringing a cross-section of knowledge to each representation. From product development and management requirements to regulatory demands and litigation risks, we have the experience and multidisciplinary approach to assist industry clients in every aspect of their business. We represent virtually every type of entity operating in or related to the life sciences industry, including many of the worlds largest pharmaceutical and medical device manufacturers.
The LSHI Group regularly publishes a wide range of alerts and bulletins in nearly every area of life sciences and health care law. To ensure that we deliver this content in the most efficient, easily-accessible and environmentally-conscious manner possible, we post many of our publications to our widely read blogs, Health Industry Washington Watch and Life Sciences Legal Update, which were specifically created to keep our health care and life sciences clients apprised of significant regulatory changes and litigation trends.
Our broad, global reach--with lawyers practicing in offices throughout the United States, including New York, California, Washington, D.C., Texas, Pennsylvania, New Jersey, Illinois, Delaware, and Virginia, as well as offices in Europe, the United Kingdom, Asia and the Middle East--allows us to seamlessly represent any life science and health industry business on a global scale.